Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences, Inc. - Common Stock (NQ: SAVA )

2.940 +0.050 (+1.73%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
34 35 Next >
Why Is Cassava Sciences (SAVA) Stock Heating Up Today?
SAVA stock rose 5% on the success of Biogen in slowing cognitive decline from Alzheimer's, but its Simufilam has a different target. 
Via InvestorPlace
US Stocks Mixed; Wholesale Inventories Increase 1.3% In August
U.S. stocks traded mixed this morning, with the Dow Jones gaining around 20 points on Wednesday. 
Via Benzinga
Why Cassava Sciences Shares Are Soaring Higher
Cassava Sciences Inc (NASDAQ: SAVA) shares are trading higher by 7.15 to $49.48 during Wednesday's pre-market session after Biogen Inc (NASDAQ: BIIB) and Eisai Co. 
Via Benzinga
Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket
Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday. 
Via Benzinga
What Is Going on With Cassava (SAVA) Stock Today?
SAVA stock remains volatile as speculators place bets on Simufilam, Cassava Sciences's Alzheimer's drug under Phase 3 study. 
Via InvestorPlace
Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks moving higher in today’s pre-market trading session. 
Via Benzinga
Caution! It’s Not Safe to Jump on the SAVA Stock Hype Train.
Rumors and speculation surrounding Cassava Sciences incited a buying frenzy in SAVA stock, but this isn't the time to jump on the hype train. 
Via InvestorPlace
US Stocks Open Higher; Dow Surges 300 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Tuesday. 
Via Benzinga
US Stocks Mostly Higher; Nasdaq Rises Over 100 Points
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday. 
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Friday, 9/23, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
BP, Costco, FedEx And Other Big Losers From Friday
U.S. stocks closed lower with the Nasdaq Composite dropping around 200 points on Friday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers 
Via Benzinga
5 Investors Betting Big on Cassava (SAVA) Stock
SAVA stock received a boost yesterday following news that the SEC had closed its case against the company. Here are its top five investors. 
Via InvestorPlace
Pain Therapeutics Stock Shows Rising Price Performance With Jump To 97 RS Rating
Pain Therapeutics sees its Relative Strength Rating enter the elite 90-plus level. 
Via Investor's Business Daily
Nasdaq Tumbles Over 200 Points; Crude Oil Drops Sharply
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Friday. 
Via Benzinga
US Stocks Open Lower; Dow Tumbles 400 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping around 400 points on Friday. 
Via Benzinga
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day... 
Via Benzinga
The Huge Reason Cassava Sciences (SAVA) Stock Is Rocketing Higher
Shares of SAVA stock are soaring higher after the SEC closed its investigation on Cassava over alleged research manipulation. 
Via InvestorPlace
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Dow Turns Higher; Crude Oil Rises 0.7%
U.S. stocks pared some losses, with the Dow Jones turning higher toward the end of trading on Thursday. 
Via Benzinga
Cassava Skyrockets After SEC Clears It Of Tampering With Alzheimer's Data
The SEC was looking into issues surrounding its experimental Alzheimer's drug. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Stocks Keep Sinking As Wall Street Comes To Terms With Fed Hike
Stocks are sinking even lower on Thursday, erasing their muted morning gains to resume yesterday's late-session selloff, which was sparked by yet another rate hike from the U.S. Federal Reserve. 
Via Talk Markets
Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session
 Gainers 
Via Benzinga
Trip.com, Albireo Pharma And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
What's Going On With Cassava Sciences Stock?
Cassava Sciences Inc (NASDAQ: SAVA) shares are trading lower on above-average volume Wednesday. Despite Wednesday's fall, the stock is still up more than 50% since mid-August. 
Via Benzinga
GIS Stock Pops as General Mills Raises Full-Year Guidance
General Mills (GIS) stock is getting a boost on Wednesday after the food company increased its full-year guidance for fiscal 2023. 
Via InvestorPlace
Stitch Fix (SFIX) Stock Sinks Following Disappointing Earnings
Stitch Fix (SFIX) stock is taking a beating on Wednesday after the company released results for its fiscal fourth quarter of 2022. 
Via InvestorPlace
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.